Headline News

Following an FDA review that found oral phenylephrine is ineffective in treating nasal congestion, the administration has proposed an order to remove the active ingredient from over-the-counter nasal decongestants.

I initially became hooked on ID when I was a medical student rounding on ID service and was evaluating a person with pneumonia who had just expectorated purulent sputum.

Upadacitinib exhibited efficacy and a favorable benefit-risk profile for the long-term treatment of moderate to severe atopic dermatitis in adolescents, according to a study.

Measles cases increased globally by 20% in 2023, and roughly 22 million children missed their first measles vaccine dose, according to the CDC and WHO’s annual global measles report.

Most people at high risk for lung cancer have not discussed screening for the disease with their clinician or have even heard of the test, according to a research letter published in JAMA Network Open.

NEW YORK — In this Healio Video Perspective from OSN New York Retina, Rishi P. Singh, MD, FASRS, of Cleveland Clinic Florida discusses the need for anti-VEGF biosimilars and the possibility of on-label bevacizumab.

Genetic variants found in hidradenitis suppurativa may be correlated to genetic variants in coronary artery disease and diabetes, according to a study.

Nov. 15 is World Vasectomy Day. It is held on the third Friday of each November to raise awareness about the role of male contraceptives in family planning.

DALLAS — Data presented at the American Association of Hip and Knee Surgeons Annual Meeting showed use of intraosseous vancomycin infusion may reduce periprosthetic joint infection vs. IV vancomycin in revision total knee arthroplasty.

CHICAGO — An AI-enabled tool utilizing machine learning, high-speed images and video accurately detected hypertension and type 2 diabetes among Japanese adults compared with continuous BP monitoring and HbA1c testing, researchers reported.